Erin Redd
Nurse Practitioner · Bloomington, ILNPI 1578711586
Payments from drug & device makers
Across 43 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$216
- Incyte Corporation$122
- LEO Pharma Inc.$116
- Arcutis Biotherapeutics, Inc.$74
- Novartis$65
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$54
- plus $172 from 6 others
What the payments were for
- Food & beverage$78896%
- Education$314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $216 |
| Incyte Corporation | 6 | $122 |
| LEO Pharma Inc. | 5 | $116 |
| Arcutis Biotherapeutics, Inc. | 1 | $74 |
| Novartis | 3 | $65 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $54 |
| Sun Pharmaceutical Industries Inc. | 3 | $48 |
| Pfizer | 3 | $47 |
| Johnson & Johnson | 2 | $40 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Organon | 3 | $5 |
How this compares
$819 in reported general payments places this provider in the 75th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 21 | $120,582 |
| Taltz AutoinjectorIxekizumab | 13 | $90,367 |
| Dupixent SyringeDupilumab | 14 | $53,656 |
| Clobetasol Propionate | 62 | $3,231 |
| Fluorouracil | 36 | $3,172 |
| Metronidazole | 35 | $2,246 |
| Ketoconazole | 146 | $2,155 |
| Betamethasone Valerate | 59 | $1,900 |
| Azelaic Acid | 13 | $1,849 |
| Triamcinolone Acetonide | 197 | $1,725 |
| Cephalexin | 46 | $1,291 |
| Betamethasone Dipropionate | 30 | $1,217 |
| Clindamycin Phosphate | 29 | $1,166 |
| Desonide | 21 | $925 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 12 | $667 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Bloomington
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.